Literature DB >> 18488021

The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein.

Xudong Zhao1, Julian Ik-Tsen Heng, Daniele Guardavaccaro, Richeng Jiang, Michele Pagano, Francois Guillemot, Antonio Iavarone, Anna Lasorella.   

Abstract

Development of the nervous system requires that timely withdrawal from the cell cycle be coupled with initiation of differentiation. Ubiquitin-mediated degradation of the N-Myc oncoprotein in neural stem/progenitor cells is thought to trigger the arrest of proliferation and begin differentiation. Here we report that the HECT-domain ubiquitin ligase Huwe1 ubiquitinates the N-Myc oncoprotein through Lys 48-mediated linkages and targets it for destruction by the proteasome. This process is physiologically implemented by embryonic stem (ES) cells differentiating along the neuronal lineage and in the mouse brain during development. Genetic and RNA interference-mediated inactivation of the Huwe1 gene impedes N-Myc degradation, prevents exit from the cell cycle by opposing the expression of Cdk inhibitors and blocks differentiation through persistent inhibition of early and late markers of neuronal differentiation. Silencing of N-myc in cells lacking Huwe1 restores neural differentiation of ES cells and rescues cell-cycle exit and differentiation of the mouse cortex, demonstrating that Huwe1 restrains proliferation and enables neuronal differentiation by mediating the degradation of N-Myc. These findings indicate that Huwe1 links destruction of N-Myc to the quiescent state that complements differentiation in the neural tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18488021      PMCID: PMC2680438          DOI: 10.1038/ncb1727

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  48 in total

Review 1.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

Authors:  Michael H Glickman; Aaron Ciechanover
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

2.  Gene-target recognition among members of the myc superfamily and implications for oncogenesis.

Authors:  R C O'Hagan; N Schreiber-Agus; K Chen; G David; J A Engelman; R Schwab; L Alland; C Thomson; D R Ronning; J C Sacchettini; P Meltzer; R A DePinho
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

3.  Expression of N-myc by neuroblastomas with one or multiple copies of the oncogene.

Authors:  R C Seeger; R Wada; G M Brodeur; T J Moss; R L Bjork; L Sousa; D J Slamon
Journal:  Prog Clin Biol Res       Date:  1988

4.  Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade.

Authors:  M Scheffner; U Nuber; J M Huibregtse
Journal:  Nature       Date:  1995-01-05       Impact factor: 49.962

5.  A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein.

Authors:  V Chau; J W Tobias; A Bachmair; D Marriott; D J Ecker; D K Gonda; A Varshavsky
Journal:  Science       Date:  1989-03-24       Impact factor: 47.728

6.  Cdc25 cell-cycle phosphatase as a target of c-myc.

Authors:  K Galaktionov; X Chen; D Beach
Journal:  Nature       Date:  1996-08-08       Impact factor: 49.962

7.  A stem cell molecular signature.

Authors:  Natalia B Ivanova; John T Dimos; Christoph Schaniel; Jason A Hackney; Kateri A Moore; Ihor R Lemischka
Journal:  Science       Date:  2002-09-12       Impact factor: 47.728

8.  Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors.

Authors:  Anna Marie Kenney; Hans R Widlund; David H Rowitch
Journal:  Development       Date:  2003-12-03       Impact factor: 6.868

9.  Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions.

Authors:  F A Peverali; D Orioli; L Tonon; P Ciana; G Bunone; M Negri; G Della-Valle
Journal:  Oncogene       Date:  1996-01-18       Impact factor: 9.867

10.  PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.

Authors:  Alessio Zippo; Alessandra De Robertis; Riccardo Serafini; Salvatore Oliviero
Journal:  Nat Cell Biol       Date:  2007-07-22       Impact factor: 28.824

View more
  133 in total

1.  Human proteome-scale structural modeling of E2-E3 interactions exploiting interface motifs.

Authors:  Gozde Kar; Ozlem Keskin; Ruth Nussinov; Attila Gursoy
Journal:  J Proteome Res       Date:  2012-01-10       Impact factor: 4.466

2.  E3 ligases Arf-bp1 and Pam mediate lithium-stimulated degradation of the circadian heme receptor Rev-erb alpha.

Authors:  Lei Yin; Shree Joshi; Nan Wu; Xin Tong; Mitchell A Lazar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

3.  E3 ubiquitin ligase Mule ubiquitinates Miz1 and is required for TNFalpha-induced JNK activation.

Authors:  Yi Yang; HanhChi Do; Xuejun Tian; Chaozheng Zhang; Xinyuan Liu; Laura A Dada; Jacob I Sznajder; Jing Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

Review 4.  Physiological functions of the HECT family of ubiquitin ligases.

Authors:  Daniela Rotin; Sharad Kumar
Journal:  Nat Rev Mol Cell Biol       Date:  2009-05-13       Impact factor: 94.444

5.  Polyubiquitination by HECT E3s and the determinants of chain type specificity.

Authors:  Hyung Cheol Kim; Jon M Huibregtse
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

6.  XLID-causing mutations and associated genes challenged in light of data from large-scale human exome sequencing.

Authors:  Amélie Piton; Claire Redin; Jean-Louis Mandel
Journal:  Am J Hum Genet       Date:  2013-07-18       Impact factor: 11.025

7.  Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.

Authors:  Elena Bonazzoli; Stefania Bellone; Luca Zammataro; Barbara Gnutti; Adele Guglielmi; Silvia Pelligra; Nupur Nagarkatti; Paola Manara; Joan Tymon-Rosario; Burak Zeybek; Gary Altwerger; Gulden Menderes; Chanhee Han; Elena Ratner; Dan-Arin Silasi; Gloria S Huang; Vaagn Andikyan; Masoud Azodi; Peter E Schwartz; Alessandro D Santin
Journal:  Gynecol Oncol       Date:  2020-06-26       Impact factor: 5.482

Review 8.  Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Authors:  Shan Wang; Dede N Ekoue; Ganesh V Raj; Ralf Kittler
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

9.  Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation.

Authors:  Gianluca Canettieri; Lucia Di Marcotullio; Azzura Greco; Sonia Coni; Laura Antonucci; Paola Infante; Laura Pietrosanti; Enrico De Smaele; Elisabetta Ferretti; Evelina Miele; Marianna Pelloni; Giuseppina De Simone; Emilia Maria Pedone; Paola Gallinari; Alessandra Giorgi; Christian Steinkühler; Luigi Vitagliano; Carlo Pedone; M Eugenià Schinin; Isabella Screpanti; Alberto Gulino
Journal:  Nat Cell Biol       Date:  2010-01-17       Impact factor: 28.824

10.  Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis.

Authors:  Francesco Niola; Xudong Zhao; Devendra Singh; Ryan Sullivan; Angelica Castano; Antonio Verrico; Pietro Zoppoli; Dinorah Friedmann-Morvinski; Erik Sulman; Lindy Barrett; Yuan Zhuang; Inder Verma; Robert Benezra; Ken Aldape; Antonio Iavarone; Anna Lasorella
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.